Page 2 - Receptor Agonists News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Roundup: Endocrinology Drug Alerts

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label updates and changes.

Drug administrationHospira incNovo nordiskReceptor agonistsEvent reporting systemWith magnetsBicarbonate injection glass syringesInsulin glargine yfgnGrowth hormoneLar depotReproductive potential

The FDA Says Ozempic Probably Won t Make You Suicidal

Good news: suicidal ideation is, according to the Food and Drug Administration, probably not among the list of bizarre side effects associated with semaglutide, the active ingredient in the diabetes injectable Ozempic and its weight management sister drug Wegovy. As the FDA said in a press release, the agency hasn't yet found any "clear relationship" between […]

United kingdomDrug administrationSuicidal ideationFood and drug administrationWeight managementActive ingredientReceptor agonistsSide effects

FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs

The Food and Drug Administration (FDA) is looking into reports of adverse side effects from using diabetes medications such as Ozempic and Mounjaro, with hair loss, suicidal thoughts and airway obstruction being among the reported complications. According to the latest information from the agency, the FDA Adverse Event Reporting System (FAERS) received reports of patients…

Drug administrationNovo nordiskEvent reporting systemFood and drug administrationSuicidal thoughtsAdverse side effectsSide effectsNovo nordiskHair lossReceived reportsAirway obstructionReceptor agonistsWeight loss

Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc , AstraZeneca PLC, Sanofi, Novo Nordisk Among Others

The "Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering.

United statesSouth koreaUnited kingdomAsia pacificNovo nordiskLaura woodEli lillyOffice hours callSurge in research development pharmaceutical sectorShanghai benemae pharmaceutical corporationJiangsu hansoh pharmaceutical group co ltdE st office hours callPfizer incGlucagon like peptideCompound annual growth rateNorth america

Global Glucagon-Like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc , Astrazeneca PLC, Sanofi, Novo Nordisk Among Others

Global Glucagon-Like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc , Astrazeneca PLC, Sanofi, Novo Nordisk Among Others
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited kingdomUnited statesLaura woodEli lillyAsia pacificNovo nordiskSurge in research development pharmaceutical sectorShanghai benemae pharmaceutical corporationJiangsu hansoh pharmaceutical group co ltdRoute of administrationOffice hours callPfizer incE st office hours callGlucagon like peptidePotential impact